Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms

medRxiv(2022)10.1101/2022.02.03.22269612Source: DataRank Database

Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: greenTopics (19)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Valentina Guerrini ORCID,Rahul Ukey ORCID,Ryan J. Dikdan ORCID,Jason H. Yang ORCID,Pankaj Kumar Mishra ORCID

Live enrichment

PubMed:35132422 OpenAlex:https://openalex.org/W4210304823

National Institutes of Health

Grant: 1R61HD105619-01

COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)

Fundação para a Ciência e a Tecnologia, I.P.

Grant: PTDC/CCI-INF/6762/2020

MS3: New foundations for micro-services and serverless systems

National Institutes of Health

Grant: 3R01AI158911-02S1

Cohort and biomarkers for COVID-19 severity, natural history, and reinfection

National Institutes of Health

Grant: 5U01AI122285-06

Microbial, immune, metabolic perturbations by antibiotics (MIME study)

National Institutes of Health

Grant: 5UL1TR003017-03

New Jersey Alliance for Clinical Translational Science: NJ ACTS

National Institutes of Health

Grant: 1S10OD025140-01A1

An Orbitrap Tribrid mass spectrometer and nanoflow LC system to upgrade the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical School

National Institutes of Health

Grant: 1R01HL149450-01A1

Foam cells as drug targets in tuberculosis

National Institutes of Health

Grant: 5R00GM118907-04

Effects of Host Metabolic Variation on Antibiotic Susceptibility

NIGMS NIH HHS

Grant: R00 GM118907

NIAID NIH HHS

Grant: U01 AI122285

NICHD NIH HHS

Grant: R61 HD105619

NCATS NIH HHS

Grant: UL1 TR003017

NIH HHS

Grant: S10 OD025140

NIAID NIH HHS

Grant: R01 AI158911

NHLBI NIH HHS

Grant: R01 HL149450

greenLicense: cc-by

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/02/03/2022.02.03.22269612.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.02.03.22269612

repositoryhttps://doi.org/10.1101/2022.02.03.22269612

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35132422

Fields of Study

COVID-19 Clinical Research StudiesBlood groups and transfusionSARS-CoV-2 and COVID-19 Research0303 health sciences03 medical and health sciences

Keywords

Convalescent plasmaCoronavirus disease 2019 (COVID-19)DiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineResolution (logic)VirologyInternal medicineComputer scienceInfectious disease (medical specialty)OutbreakArtificial intelligenceArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being